ArticleDrugs in R&D2015

Evaluation of the Safety and Effectiveness of Add-On Tacrolimus in Patients with Rheumatoid Arthritis Who Failed to Show an Adequate Response to Biological DMARDs: The Interim Results of a Specific Drug Use-Results Survey of Tacrolimus.

Kota Ishida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.